Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where Scott Weaver is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Flavivirus and Alphavirus ReVAMPP (FLARE - Research Project 4)
Weaver, S. (PI)
Washington University in St.Louis ( Award #1U19AI18196001)
8/12/24 → 7/31/25
Project: Research project
-
Structural and functional studies of alphavirus receptors
Weaver, S. (PI)
Harvard University ( Award #5R01AI18237702)
2/7/24 → 12/31/25
Project: Research project
-
A Novel RNA Vaccine Platform Using Circular RNA Against Chikungunya
Weaver, S. (PI)
Houston Methodist Research Institute ( Award # )
1/18/24 → 1/18/26
Project: Research project
-
PROTECT: PROtective host Targeted Engineered CRISPR-CasTherapeutics
Weaver, S. (PI)
Lawrence Livermore National Security , LLC ( Award #DEAC5207NA27344)
3/21/23 → 9/30/25
Project: Research project
-
Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN)
Weaver, S. (PI)
Fogarty International Center ( Award #5D43TW01224603)
3/1/22 → 2/28/27
Project: Research project
-
Advanced photohydrolysis technology demonstrates rapid inactivation of aerosolized SARS-CoV-2 and efficacy against other respiratory viral pathogens
Peel, J. E., Jardinella, E., Qu, Y., Plante, J., Mitchell, B. M., Walker, J. L., Garofalo, R. P., Weaver, S. C., Plante, K. S., Brasel, T. & Lawrence, W. S., 2025, (Accepted/In press) In: American Journal of Infection Control.Research output: Contribution to journal › Article › peer-review
Open Access -
Antiviral and immunomodulatory effects of ouabain against congenital Zika syndrome model
Carvalho, D. C. M., Dunn, T., Kroon Campos, R., Tierney, J. A., Onyoni, F., Cavalcante-Silva, L. H. A., Pena, L. J., Rodrigues-Mascarenhas, S., Wu, P. & Weaver, S. C., 2025, (Accepted/In press) In: Molecular Therapy.Research output: Contribution to journal › Article › peer-review
-
Cross-neutralizing activity of the chikungunya vaccine VLA1553 against three prevalent chikungunya lineages
Kosulin, K., Brasel, T., Smith, J., Torres, M., Bitzer, A., Dubischar, K., Buerger, V., Mader, R., Weaver, S., Beasley, D. W. C. & Hochreiter, R., 2025, In: Emerging Microbes and Infections. 14, 1, 2469653.Research output: Contribution to journal › Article › peer-review
Open Access -
High-resolution spatiotemporal analysis of chikungunya epidemics between 2019 and 2020 in Salvador, Brazil: a municipality-level transmission dynamics study
Argibay, H. D., Cardoso, C. W., De Souza, W., Souza, R. L., Pellizzaro, M., Cunha, G. M., Clennon, J., Weaver, S. C., Reis, M. G., Kitron, U. & Ribeiro, G. S., Mar 2025, In: The Lancet Regional Health - Americas. 43, 101003.Research output: Contribution to journal › Article › peer-review
Open Access -
Optimization of a panel of behavioral tests for use in containment using a golden Syrian hamster model
Reyna, R. A., Walker, J., Viveros, A., Mitchell, B., Dulaney, E., Shinde, D. P., Plante, J., Kocsis, A., Ntiforo, C., Weaver, S. & Plante, K. S., Jun 2025, In: Journal of Virological Methods. 335, 115132.Research output: Contribution to journal › Article › peer-review
Open Access